104 related articles for article (PubMed ID: 9731487)
1. Cancer-associated expression of glycolipid sulfotransferase gene in human renal cell carcinoma cells.
Honke K; Tsuda M; Hirahara Y; Miyao N; Tsukamoto T; Satoh M; Wada Y
Cancer Res; 1998 Sep; 58(17):3800-5. PubMed ID: 9731487
[TBL] [Abstract][Full Text] [Related]
2. [Sulfolipids and glycolipid sulfotransferases in a human renal cell carcinoma cell line].
Kobayashi T
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):522-30. PubMed ID: 1427596
[TBL] [Abstract][Full Text] [Related]
3. Involvement of protein kinase C in the regulation of glycolipid sulfotransferase activity levels in renal cell carcinoma cells.
Kobayashi T; Honke K; Gasa S; Sugiura M; Miyazaki T; Ishizuka I; Makita A
Cancer Res; 1993 Jun; 53(11):2484-9. PubMed ID: 8098660
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the regulation of glycolipid sulfotransferase activity in human renal cancer cells].
Yabunaka N
Hokkaido Igaku Zasshi; 1995 Mar; 70(2):289-300. PubMed ID: 7774881
[TBL] [Abstract][Full Text] [Related]
5. Regulation of activity levels of glycolipid sulfotransferases by transforming growth factor alpha in renal cell carcinoma cells.
Kobayashi T; Honke K; Gasa S; Imai S; Tanaka J; Miyazaki T; Makita A
Cancer Res; 1993 Dec; 53(23):5638-42. PubMed ID: 7902207
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor elevates the activity levels of glycolipid sulfotransferases in renal-cell-carcinoma cells.
Kobayashi T; Honke K; Gasa S; Kato N; Miyazaki T; Makita A
Int J Cancer; 1993 Sep; 55(3):448-52. PubMed ID: 8104164
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Ras in the expression of glycolipid sulfotransferase in human renal cancer cells.
Yabunaka N; Honke K; Ishii A; Ogiso Y; Kuzumaki N; Agishi Y; Makita A
Int J Cancer; 1997 May; 71(4):620-3. PubMed ID: 9178817
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells.
Balbaa M; Honke K; Makita A
Biochim Biophys Acta; 1996 Jan; 1299(1):141-5. PubMed ID: 8555246
[TBL] [Abstract][Full Text] [Related]
9. Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential.
Satoh M; Handa K; Saito S; Tokuyama S; Ito A; Miyao N; Orikasa S; Hakomori S
Cancer Res; 1996 Apr; 56(8):1932-8. PubMed ID: 8620516
[TBL] [Abstract][Full Text] [Related]
10. Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells.
Kobayashi T; Honke K; Kamio K; Sakakibara N; Gasa S; Miyao N; Tsukamoto T; Ishizuka I; Miyazaki T; Makita A
Br J Cancer; 1993 Jan; 67(1):76-80. PubMed ID: 8094007
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor elevates the activity levels of glycolipid sulfotransferases in renal cell carcinoma cells.
Kobayashi T; Honke K; Gasa S; Miyazaki T; Tajima H; Matsumoto K; Nakamura T; Makita A
Eur J Biochem; 1994 Jan; 219(1-2):407-13. PubMed ID: 8307006
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated alternative usage of multiple promoters of human GalCer sulfotransferase gene.
Tsuda M; Egashira M; Niikawa N; Wada Y; Honke K
Eur J Biochem; 2000 May; 267(9):2672-9. PubMed ID: 10785389
[TBL] [Abstract][Full Text] [Related]
13. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
14. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.
Tochizawa S; Masumori N; Yanai Y; Ohmoto Y; Yabuuchi Y; Tsukamoto T
Biomed Res; 2008 Dec; 29(6):271-8. PubMed ID: 19129670
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma.
Tanaka T; Torigoe T; Hirohashi Y; Sato E; Honma I; Kitamura H; Masumori N; Tsukamoto T; Sato N
J Cancer Res Clin Oncol; 2014 Mar; 140(3):503-13. PubMed ID: 24477694
[TBL] [Abstract][Full Text] [Related]
17. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
[TBL] [Abstract][Full Text] [Related]
20. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H
Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
